Evidence for bicarbonate-dependent lithium reabsorption in dog kidneys

Area of Science:

• Nephrology
• Renal Physiology
• Pharmacology

Background:

• Understanding lithium transport mechanisms is crucial for managing lithium therapy and renal function.
• Previous studies suggested potential routes for lithium reabsorption, but definitive evidence was lacking.

Purpose of the Study:

• To elucidate the specific route (transcellular or paracellular) of lithium reabsorption in the kidney.
• To investigate the driving forces behind lithium reabsorption.

Main Methods:

• Experiments were conducted on anesthetized, volume-expanded dogs with controlled glomerular filtration rate (GFR).
• Inhibitors of Na, K-ATPase (ouabain) and transcellular NaCl reabsorption (ethacrynic acid) were used.
• The effects of acetazolamide (inhibiting bicarbonate reabsorption) and mannitol (reducing osmotic transport) on lithium reabsorption were assessed.

Main Results:

• Ouabain and ethacrynic acid did not inhibit lithium or bicarbonate reabsorption.
• Lithium reabsorption increased with plasma lithium concentration, indicating passive transport.
• Acetazolamide significantly reduced both bicarbonate and lithium reabsorption, suggesting a link.
• Mannitol reduced lithium and chloride reabsorption proportionally to acetazolamide's effect.
• Combined acetazolamide and mannitol administration drastically reduced fractional lithium reabsorption.

Conclusions:

• Lithium is reabsorbed passively along a paracellular route in the kidney.
• This passive reabsorption is driven by osmotic forces generated by transcellular sodium bicarbonate (NaHCO3) reabsorption.
• Active transport mechanisms do not play a significant role in lithium reabsorption.